Michael Kishbauch

2007

In 2007, Michael Kishbauch earned a total compensation of $1.2M as Director, President, and Chief Executive Officer at Achillion Pharmaceuticals, a 44% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$127,050
Option Awards$719,496
Salary$363,000
Other$10,531
Total$1,220,077

Kishbauch received $719.5K in option awards, accounting for 59% of the total pay in 2007.

Kishbauch also received $127.1K in non-equity incentive plan, $363K in salary and $10.5K in other compensation.

Rankings

In 2007, Michael Kishbauch's compensation ranked 3,536th out of 8,700 executives tracked by ExecPay. In other words, Kishbauch earned more than 59.4% of executives.

ClassificationRankingPercentile
All
3,536
out of 8,700
59th
Division
Manufacturing
1,260
out of 3,314
62nd
Major group
Chemicals And Allied Products
240
out of 746
68th
Industry group
Drugs
133
out of 546
76th
Industry
Pharmaceutical Preparations
101
out of 364
72nd
Source: SEC filing on April 24, 2008.

Kishbauch's colleagues

We found four more compensation records of executives who worked with Michael Kishbauch at Achillion Pharmaceuticals in 2007.

2007

Milind Deshpande

Achillion Pharmaceuticals

Chief Scientific Officer

2007

Gautam Shah

Achillion Pharmaceuticals

Senior Vice President and Chief Compliance Officer

2007

Mary Fenton

Achillion Pharmaceuticals

Chief Financial Officer

2007

John Pottage

Achillion Pharmaceuticals

Chief Medical Officer

In-depth

You may also like